Giacomo Forti

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

Antonio Tursi, Giovanni Brandimarte, Alfredo Papa et al. · The American Journal of Gastroenterology · 2010 · 483 citations · Full text

Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.

Antonio Tursi, Giovanni Brandimarte, Gian Marco Giorgetti et al. · PubMed · 2004 · 241 citations

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

Antonio Tursi, Giovanni Brandimarte, Walter Elisei et al. · Alimentary Pharmacology & Therapeutics · 2013 · 152 citations · Full text

Development and Validation of an Endoscopic Classification of Diverticular Disease of the Colon: The DICA Classification

Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario et al. · Digestive Diseases · 2014 · 80 citations

Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study

Antonio Tursi, Giovanni Brandimarte, Francesco Di Mario et al. · United European Gastroenterology Journal · 2015 · 48 citations · Full text